arXiv.itsnick.co

an independent field guide to 23 million papers from arXiv & OpenAlex — not affiliated with arXiv.org

Computer Science · Artificial Intelligence

RESEARCH ARTICLE Assay Reproducibility in Clinical Studies of Plasma miRNA

Jonathan Rice, Henry Roberts, James Burton, Jianmin Pan, Vanessa States, N. Rai, Susan Gal

See on the map

Abstract

There are increasing reports of plasma miRNAs as biomarkers of human disease but few standards in methodologic reporting, leading to inconsistent data. We systematically re-viewed plasma miRNA studies published between July 2013-June 2014 to assess method-ology. Six parameters were investigated: time to plasma extraction, methods of RNA extraction, type of miRNA, quantification, cycle threshold (Ct) setting, and methods of statis-tical analysis. We compared these data with a proposed standard methodologic technique. Beginning with initial screening for 380 miRNAs using microfluidic array technology and val-idation in an additional cohort of patients, we compared 11 miRNAs that exhibited differen-tial expression between 16 patients with benign colorectal neoplasms (advanced adenomas) and 16 patients without any neoplasm (controls). Plasma was isolated immedi-ately, 12, 24, 48, or 72 h following phlebotomy. miRNA was extracted using two different techniques (Trizol LS with pre-amplification or modified miRNeasy). We performed Taq-man-based RT-PCR assays for the 11 miRNAs with subsequent analyses using a variable Ct setting or a fixed Ct set at 0.01, 0.03, 0.05, or 0.5. Assays were performed in duplicate by

More like this